Skip header and navigation
Canadian Medical Association
  • CMA Policybase
  • Home
  • Help
  • Selections 0
  • Response to consultation
  • Pharmaceuticals, prescribing, cannabis, drugs
Print
Sort by Relevance Sort by Newest Sort by Oldest
Gallery View List View
Refine Your Search

Narrow Results By

Topic

  • Health care and patient safety 14
  • Pharmaceuticals, prescribing, cannabis, drugs
  • Population health, health equity, public health 5

Policy Type

  • Court submission 1
  • Parliamentary submission 4
  • Policy document 1
  • Response to consultation

Year

  • 2018 3
  • 2017 1
  • 2016 3
  • 2014 1
  • Advanced Search
  • Help

8 records – page 1 of 1.

Prev Next
Select Title Policy Type Year
EspAddText
EspRemoveText
Consultation on proposed front-of-package labelling Response to consultation 2018
EspAddText
EspRemoveText
Consultation on the renewal of Federal Tobacco Control Strategy Response to consultation 2017
EspAddText
EspRemoveText
Health Canada consultation on tobacco products regulations (plain and standardized appearance) Response to consultation 2018
EspAddText
EspRemoveText
Health Canada’s Consultation on “Plain and Standardized Packaging” Response to consultation 2016
EspAddText
EspRemoveText
Implementation of National Pharmacare Response to consultation 2018
EspAddText
EspRemoveText
Regulation of Self-Care Products in Canada Response to consultation 2016
EspAddText
EspRemoveText
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions. Response to consultation 2016
EspAddText
EspRemoveText
Tamper Resistance under the Controlled Drugs and Substances Act Response to consultation 2014

8 records – page 1 of 1.

Prev Next
  • Privacy
  • Terms & Conditions
  • Accessibility
  • Contact

© 2023 Canadian Medical Association